Texas Biostetic Instruments Acquires Rights for Exclusive Distributorship of Atache in the United States

Texas Biostetic Instruments (TBI) has acquired the rights for exclusive distributorship of Atache in the United States. Atache is now part of the product division. Nelson Thibodeaux, president of TBI stated, “TBI continues to expand our products, equipment, and services to the skin care industry. With 30 years of experience in the field of dermatology, Atache offers new technology known as telomerase activity.”

[load_comments_template pid="263452"]
Share this story
Related stories
Register